News - Financial

Filter

Current filters:

Financial

Popular Filters

1 to 25 of 1492 results

Ranbaxy down on same quarter last year following FDA fine

Ranbaxy down on same quarter last year following FDA fine

30-07-2014

Indian generic pharma company Ranbaxy, has reported consolidated sales of 23.7 billion rupees ($394 million),…

BSE SensexFinancialGenericsIndiaOver-the-counter accountingPharmaceutical industryRanbaxyRanbaxy Laboratories

Almirall's top-performing product in first half of 2014 is part of AstraZeneca selloff

Almirall's top-performing product in first half of 2014 is part of AstraZeneca selloff

30-07-2014

Spanish drug company Almirall has announced total revenues of 433.4 million euros ($508.8 million) for…

AlmirallEkliraEuroFinancialNabiximolsPharmaceuticalSpain

Amgen’s 2nd-qtr beats expectations, but firm slashes workforce

Amgen’s 2nd-qtr beats expectations, but firm slashes workforce

30-07-2014

Amgen, the largest global independent biotech firm, reported a 23% leap in second-quarter 2014 profit…

AmgenBiotechnologyFinancialManagement

Merck's revenue drops 1% but still beats analysts' estimates for 2nd-qtr

Merck's revenue drops 1% but still beats analysts' estimates for 2nd-qtr

29-07-2014

Global revenue at pharma giant Merck & Co slipped 1% but the company has still exceeded analysts’ estimates…

FinancialFinancial accountingGardasilHepatitis CIsentressMerckMerck & CoNasonexPharma giantPharmaceuticalRemicadeUSAVytorinZetia

Earnings at Pfizer tank but still just beat expectations

Earnings at Pfizer tank but still just beat expectations

29-07-2014

Taking the brunt of generic competition to former blockbuster drugs, US pharma giant Pfizer posted a…

FinancialPfizerPharmaceuticalUSA

Recordati reports first half results with sales up 6.3%

Recordati reports first half results with sales up 6.3%

29-07-2014

Italian drugmaker Recordati saw its shares rise 2.1% to 12.30 euros after the company released first…

FinancialItalyPharmaceuticalRecordatiZanidip

Reckitt Benckiser to spin out pharma; GSK views Consumer options

Reckitt Benckiser to spin out pharma; GSK views Consumer options

28-07-2014

UK-based consumer goods giant Reckitt Benckiser plans to spin off its USA-based pharmaceutical business,…

FinancialGlaxoSmithKlineMergers & AcquisitionsNeurologicalPharmaceuticalReckitt BenckiserSuboxoneUK

Zealand and Boehringer link up to advance novel peptide medicines

Zealand and Boehringer link up to advance novel peptide medicines

28-07-2014

Denmark’s Zealand Pharma has entered into a new global exclusive licence and R&D collaboration with…

Boehringer IngelheimCardio-vascularDenmarkFinancialGermanyLicensingMetabolicsPharmaceuticalResearchZealand Pharma

Pharmaceuticals, a strategic sector for the UK government

Pharmaceuticals, a strategic sector for the UK government

28-07-2014

Britain’s pharmaceuticals sector, which includes AstraZeneca and GlaxoSmithKline, two drugmakers among…

AstraZenecaEconomy of the United KingdomFinancialGlaxoSmithKlineMarkets & MarketingPharmaceuticalResearchUK

EMA’s CHMP backs approval of two new treatment options for rare cancers

EMA’s CHMP backs approval of two new treatment options for rare cancers

26-07-2014

The European Medicines Agency's Committee for Medicinal Products for Human Use, at its July meeting,…

BiotechnologyEuropeFinancialGilead SciencesImbruvicaJanssen BiotechJohnson & JohnsonOncologyRegulationZydelig

AbbVie 2nd-qtr 2014 earnings beat forecasts

25-07-2014

US drugmaker AbbVie, which has just clinched a $55 billion deal to acquire Ireland-based Shire, reported…

AbbVieFinancialHumiraPharmaceutical

Taiho Pharma and Sumitomo Dainippon both invest in Remiges BioPharma Fund

25-07-2014

Japanese oncology-focussed drugmaker Taiho Pharmaceutical has said that it will be investing $30 million…

BiotechnologyDainippon Sumitomo PharmaFinancialJapanOncologyRemiges BioPharma FundTaiho Pharmaceutical

PhRMA comments on Medicare Rights Center paper

25-07-2014

“Finding viable solutions to contain Medicare costs is critically important, but imposing price controls…

FinancialHealthcarePharmaceuticalPricingUSA

Glenmark reports strong growth everywhere but the USA

Glenmark reports strong growth everywhere but the USA

25-07-2014

India-based generics manufacturer Glenmark has seen its consolidated revenue increase by more than 20%…

FinancialGenericsGlenmark PharmaceuticalsIndia

Eli Lilly 2nd-qtr sales takes hit from generics; net income falls 39%

24-07-2014

US pharma major Eli Lilly reported second quarter 2014 revenues fell 17% to $4.935 billion, reflecting…

Eli LillyFinancialPharmaceutical

Celgene posts strong sales and earnings for 2nd-qtr

24-07-2014

US biotech firm Celgene reported net product sales of $1,845 million for the second quarter of 2014,…

BiotechnologyCelgene Corp.Financial

Gilead beats forecasts as Sovaldi sales soar

Gilead beats forecasts as Sovaldi sales soar

24-07-2014

US anti-virals specialist biotech firm Gilead Sciences has reported surging second-quarter 2014 sales…

Anti-viralsBiotechnologyBusiness FinanceBusiness FinanceChemistryFinancialFixed dose combinationGilead SciencesSovaldiTenofovir

Currency takes toll on Roche first-half results

Currency takes toll on Roche first-half results

24-07-2014

Swiss pharma major Roche, the world’s leading oncology company, this morning posted first-half 2014…

FinancialOncologyPharmaceuticalRocheSwitzerland

GlaxoSmithKline slashes forecast as 2nd-qtr sales and earnings fall sharply

GlaxoSmithKline slashes forecast as 2nd-qtr sales and earnings fall sharply

23-07-2014

UK pharma giant GlaxoSmithKline saw its shares fall 3.9% to £45.94 shortly after the company reported…

FinancialFluticasone propionateGlaxoSmithKlinePharmaceuticalPulmonologyUK

Biogen Idec’s 2nd-qtr 40% revenues growth beats forecasts

Biogen Idec’s 2nd-qtr 40% revenues growth beats forecasts

23-07-2014

Shares of US biotech firm Biogen Idec jumped 7.35% to $326 in pre-market trading today, as the company…

AlprolixBiogen IdecBiotechnologyElocateFinancialImmunologyPharmacologyTecfideraUSA

Merck strengthens commitment to Chinese growth market

Merck strengthens commitment to Chinese growth market

23-07-2014

Germany’s Merck KGaA, a leading company for high-tech products in the pharmaceutical and chemical sectors,…

ChinaFinancialMerckMerck KGaAPharmaceuticalProductionResearch

South Africa’s NAPM calls for elimination of VAT on medicines

22-07-2014

South African trade group the National Association of Pharmaceutical Manufacturers (NAPM) has proposed…

FinancialGenericsNational Association of Pharmaceutical ManufacturersPoliticsPricingSouth Africa

Regeneus's human cancer vaccine pipeline adds almost $4 million to valuation

Regeneus's human cancer vaccine pipeline adds almost $4 million to valuation

22-07-2014

Australian biotech company Regeneus has expanded its portfolio to include licensing of global rights…

AustraliaBiotechnologyFinancialOncologyOsteosarcomaRegeneusResearchSarcoma

1 to 25 of 1492 results

Back to top